FDA Inspection 1068791 — Basiem LLC
The FDA completed an inspection of Basiem LLC on September 19, 2018 in Madisonville, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 19, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Madisonville, LA (United States)